The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses - Pécheur, Eve-Isabelle; Borisevich, Viktoriya; Halfmann, Peter; Morrey, John D.; Smee, Donald F.; Prichard, Mark; Mire, Chad E.; Kawaoka, Yoshihiro; Geisbert, Thomas W.; Polyak, Stephen J. (Journal of Virology, 2016)
Keywords: [SDV.CAN]Life Sciences [q-bio]/Cancer; Animals; Antiviral Agents; Antiviral Agents - pharmacology; Cancer; Cell Line; Cells; drug effects; Family; France; Global Health; Growth; Hepatitis; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; immunology; Indoles; Indoles - pharmacology; Infection; Laboratories; Life Sciences; Medicine; Microbial Sensitivity Tests; microbiology; Models, Molecular; Molecular; Molecular Structure; mortality; Pediatrics; pharmacology; Stomatitis; Time; Vaccines and Antiviral Agents; virology; Virus Internalization; Virus Internalization - drug effects; Virus Replication; Virus Replication - drug effects; Viruses; Viruses - drug effects; Pediatrics; Laboratories; Growth; Humans; Viruses; Time; Molecular; Virus Internalization; Microbial Sensitivity Tests; Hepatitis; pharmacology; Molecular Structure; Hepatitis B virus; Indoles; France; immunology; Cell Line; Global Health; microbiology; drug effects; Antiviral Agents; Cells; Medicine; Infection; Stomatitis; Animals; Virus Replication; virology; mortality; Family; Models; Hepatitis C; Hepatitis B